Related references
Note: Only part of the references are listed.Antibody Directed Enzyme Prodrug Therapy (ADEPT): Trials and tribulations
Surinder K. Sharma et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Albumin-binding caspase-cleavable prodrug that is selectively activated in radiation exposed local tumor
Seung Woo Chung et al.
BIOMATERIALS (2016)
Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models
Fu Li et al.
CANCER RESEARCH (2016)
Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated Apoptosis
Seung Woo Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Gene-Directed Enzyme Prodrug Therapy
Jin Zhang et al.
AAPS JOURNAL (2015)
FITC-Conjugated Cyclic RGD Peptides as Fluorescent Probes for Staining Integrin αvβ3/αvβ5 in Tumor Tissues
Yumin Zheng et al.
BIOCONJUGATE CHEMISTRY (2014)
Tumor heterogeneity confounds and illuminates
Maria Kleppe et al.
NATURE MEDICINE (2014)
Cancer heterogeneity: implications for targeted therapeutics
R. Fisher et al.
BRITISH JOURNAL OF CANCER (2013)
Extraction protocol and mass spectrometry method for quantification of doxorubicin released locally from prodrugs in tumor tissue
Stuart Ibsen et al.
JOURNAL OF MASS SPECTROMETRY (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
Tumor heterogeneity and its implication for drug delivery
Tracy A. Denison et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Species difference of esterase expression and hydrolase activity in plasma
Fatma Goksin Bahar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intra-tumour heterogeneity: a looking glass for cancer?
Andriy Marusyk et al.
NATURE REVIEWS CANCER (2012)
Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel
Anat Eldar-Boock et al.
BIOMATERIALS (2011)
Integrin Targeted Delivery of Chemotherapeutics
Kai Chen et al.
THERANOSTICS (2011)
A simple HPLC method for doxorubicin in plasma and tissues of nude mice
Ahmed M. Al-Abd et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Caspase-3 is activated and rapidly released from human umbilical vein endothelial cells in response to lipopolysaccharide
Toshikazu Shioiri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Paul Ehrlich's magic bullet concept: 100 years of progress
Klaus Strebhardt et al.
NATURE REVIEWS CANCER (2008)
In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice
Zhuang Liu et al.
NATURE NANOTECHNOLOGY (2007)
Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell)
Florence Meyer-Losic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma
B Li et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Ligand-targeted therapeutics in anticancer therapy
TM Allen
NATURE REVIEWS CANCER (2002)
In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells
H Hentze et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Secreted human β-glucuronidase:: a novel tool for gene-directed enzyme prodrug therapy
D Weyel et al.
GENE THERAPY (2000)
Share Paper
